Optiver Holding
SANA icon

Optiver Holding’s Sana Biotechnology SANA Stock Holding History

Optiver Holding’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62K Buy
561
+52
+10% +$205 ﹤0.01% 1931
2025
Q4 		$2.07K Sell
509
-1,330
-72% -$5.96K ﹤0.01% 1998
2025
Q3 		$6.53K Buy
1,839
+1,822
+10,718% +$6.59K ﹤0.01% 1548
2025
Q2 		$46 Sell
17
-566
-97% -$1.17K ﹤0.01% 1428
2025
Q1 		$979 Buy
+583
New +$1.63K ﹤0.01% 1275
2024
Q3 		– Sell
-117
Closed -$639 – 1072
2024
Q2 		$639 Buy
+117
New +$932 ﹤0.01% 870

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Optiver Holding's SANA Position: Q1 2026 in Review

Optiver Holding increased its Sana Biotechnology (SANA) stake by 10% in Q1 2026, buying an estimated $205 and bringing the position to 561 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Optiver Holding first reported a position in SANA in Q2 2024 and has held it in 6 quarters since. The position peaked at $6.53K in Q3 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Optiver Holding held 561 shares of Sana Biotechnology worth $1.62K as of Q1 2026.
  • Optiver Holding bought 52 Sana Biotechnology shares in Q1 2026, an estimated $205.
  • Sana Biotechnology made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1931 holding.
  • Optiver Holding first reported a position in Sana Biotechnology in Q2 2024 and has held it in 6 quarters since.
  • Optiver Holding's Sana Biotechnology position peaked at $6.53K in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.